WaveMan · Form 4
Schiff Andrew N insider trades
> Search tickers & screens ⌘K
LIVE

Schiff Andrew N insider trades

Schiff Andrew N has filed 19 Form 4s with the SEC that we hold, for Aclaris Therapeutics, Inc. (ACRS) (Director), Monte Rosa Therapeutics, Inc. (GLUE) (Director) and ELEV (10% owner). Across all of them we count 0 purchases worth $0 and 12 sales worth $3.6M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 41,160 shares of Aclaris Therapeutics, Inc. worth $702.2K, dated 2022-11-11. The first filing on our record is dated 2022-06-06 and the latest 2026-06-12.

Aclaris Therapeutics, Inc. (ACRS)

Director · 12 filings · 12 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-06-17S, sale reported on Form 419,565$296.2K2022-06-21
2022-10-04S, sale reported on Form 47,700$123.3K2022-10-06
2022-10-06S, sale reported on Form 437,839$625.9K2022-10-06
2022-10-07S, sale reported on Form 47,324$118.4K2022-10-11
2022-10-17S, sale reported on Form 419,944$320.1K2022-10-19
2022-10-18S, sale reported on Form 432,093$542.1K2022-10-19
2022-10-24S, sale reported on Form 414,616$248.6K2022-10-26
2022-10-25S, sale reported on Form 412,018$204.5K2022-10-26
2022-10-26S, sale reported on Form 414,540$247.3K2022-10-26
2022-11-10S, sale reported on Form 411,395$193.9K2022-11-14
2022-11-11S, sale reported on Form 441,160$702.2K2022-11-14
2022-11-14S, sale reported on Form 41,371$23.4K2022-11-14

Monte Rosa Therapeutics, Inc. (GLUE)

Director · 5 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

ELEV (ELEV)

10% owner · 2 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1172252) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms